Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

ILA 181.1

(0.39%)

Inventory Summary of Novolog (Pharm-Up 1966) Ltd

Novolog (Pharm-Up 1966) Ltd's latest annual inventory in 2023 was 247.33 Million ILS , up 30.84% from previous year.
Novolog (Pharm-Up 1966) Ltd's latest quarterly inventory in 2024 Q2 was 226.7 Million ILS , down -2.29% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported annual inventory of 189.03 Million ILS in 2022, up 1.2% from previous year.
Novolog (Pharm-Up 1966) Ltd reported annual inventory of 186.79 Million ILS in 2021, down -26.93% from previous year.
Novolog (Pharm-Up 1966) Ltd reported quarterly inventory of 232 Million ILS for 2024 Q1, down -6.2% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported quarterly inventory of 223.7 Million ILS for 2023 Q3, down -5.17% from previous quarter.

Annual Inventory Chart of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Historical Annual Inventory of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Year	Inventory	Inventory Growth
2023	247.33 Million ILS	30.84%
2022	189.03 Million ILS	1.2%
2021	186.79 Million ILS	-26.93%
2020	255.64 Million ILS	19.15%
2019	214.54 Million ILS	18.41%
2018	181.18 Million ILS	-26.12%
2017	245.24 Million ILS	-0.1%
2016	245.5 Million ILS	6.22%
2015	231.13 Million ILS	-27.9%
2014	320.55 Million ILS	0.0%

Year	Inventory	Inventory Growth
2024 Q2	226.7 Million ILS	-2.29%
2024 Q1	232 Million ILS	-6.2%
2023 Q3	223.7 Million ILS	-5.17%
2023 Q2	235.89 Million ILS	21.04%
2023 Q1	194.88 Million ILS	3.1%
2023 FY	247.33 Million ILS	30.84%
2023 Q4	247.33 Million ILS	10.56%
2022 Q4	189.03 Million ILS	-4.81%
2022 FY	189.03 Million ILS	1.2%
2022 Q2	213.86 Million ILS	40.18%
2022 Q1	152.56 Million ILS	-18.32%
2022 Q3	198.58 Million ILS	-7.15%
2021 Q3	210.32 Million ILS	-3.73%
2021 Q2	218.47 Million ILS	-3.51%
2021 FY	186.79 Million ILS	-26.93%
2021 Q1	226.43 Million ILS	-11.42%
2021 Q4	186.79 Million ILS	-11.19%
2020 Q1	158.75 Million ILS	-26.0%
2020 Q3	270.41 Million ILS	13.76%
2020 Q2	237.71 Million ILS	49.73%
2020 FY	255.64 Million ILS	19.15%
2020 Q4	255.64 Million ILS	-5.46%
2019 Q1	128.96 Million ILS	-28.82%
2019 FY	214.54 Million ILS	18.41%
2019 Q4	214.54 Million ILS	13.42%
2019 Q3	189.16 Million ILS	26.9%
2019 Q2	149.06 Million ILS	15.59%
2018 Q4	181.18 Million ILS	-16.28%
2018 FY	181.18 Million ILS	-26.12%
2018 Q1	200.13 Million ILS	-18.4%
2018 Q2	204.65 Million ILS	2.26%
2018 Q3	216.4 Million ILS	5.74%
2017 Q2	178.33 Million ILS	-8.42%
2017 Q1	194.73 Million ILS	-20.68%
2017 Q3	257.07 Million ILS	44.15%
2017 Q4	245.24 Million ILS	-4.6%
2017 FY	245.24 Million ILS	-0.1%
2016 Q1	- ILS	-100.0%
2016 FY	245.5 Million ILS	6.22%
2016 Q4	245.5 Million ILS	6.79%
2016 Q3	229.89 Million ILS	0.0%
2015 Q4	231.13 Million ILS	0.0%
2015 FY	231.13 Million ILS	-27.9%
2014 FY	320.55 Million ILS	0.0%

Peer Inventory Comparison of Novolog (Pharm-Up 1966) Ltd

Name	Inventory	Inventory Difference